MHRA: addiction warnings on meds

After a safety review by the Medicines and Healthcare products Regulatory Agency, warnings on the packaging and patient information leaflets for gabapentinoids, benzodiazepines and z-drugs are being strengthened to better inform patients and healthcare professionals of the risks of dependency, addiction, withdrawal and tolerance.